ENTITY
Terumo Corp

Terumo Corp (4543 JP)

188
Analysis
Health Care • Japan
TERUMO CORPORATION is a manufacturer and supplier of pharmaceuticals and medical tools and equipment. The Company's products include health foods, transfusion and infusion equipment, disposable medical supply, clinical testing systems, artificial organs, and electronic thermometers. Terumo markets the products through its subsidiaries and sales offices in the US, Europe, and Asia.
more
bearish•Sanrio
•26 Nov 2024 16:04

Sanrio (8136 JP): A US$840 Million Secondary Offering

The offering as a percentage of outstanding shares and ADV is small compared to the recent large Japanese placement. Looking at recent large...

Logo
716 Views
Share
•25 Nov 2024 15:09

Kansai Electric Power (9503 JP): The Current Playbook

The offering will likely be priced on 26 November. KEPCO's share decline is the second-highest among recent large placements. The average large...

Logo
623 Views
Share
•22 Nov 2024 05:50

Kansai Electric US$3.5bn Deal Updates - Has Delivered a Decent Correction, as Compared to past Deals

Kansai Electric Power (9503 JP) plans to raise up to US$3.5bn (including over-allocation) to partly fund its investment plans. In this note, we...

Logo
597 Views
Share
bullish•Terumo Corp
•18 Nov 2024 17:50

Terumo Corp (4543 JP): Strong H1 Result Triggers Guidance Raise; Product Pipeline Entails Visibility

​Terumo reports record high H1FY25 revenue, operating profit, and net profit, driven by strong growth in C&V and blood center business. FY25...

Logo
497 Views
Share
•13 Nov 2024 21:49

Kansai Electric Power (9503 JP): A US$3.5 Billion Primary/Secondary Offering

Looking at recent large Japanese placements is instructive for understanding the potential offer price. The pricing date will fall between 26 and...

Logo
507 Views
Share
x